FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002186719> ?p ?o ?g. }

• W2002186719 endingPage "158" @default.
• W2002186719 startingPage "133" @default.
• W2002186719 abstract "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively destroys dopaminergic neurons of the substantia nigra pars compacta in humans and other primates, producing a parkinsonian condition. MPTP is metabolized to the toxin 1-methyl-4-phenylpyridine (MPP+) which is taken up by dopamine terminals. The subsequent events culminating in cell death in the substantia nigra pars compacta are not understood. To examine these events we first produced a chronic hemiparkinsonian condition in monkeys by administering a toxic dose of MPTP via the right carotid artery. One year later, these monkeys were given a trace dose of [14C]MPTP intravenously and allowed to survive 1, 3, or 10 days. In two acute conditions, monkeys were either given the radiolabeled trace dose intravenously immediately following the toxic intracarotid dose, or were given a single toxic intracarotid radiolabeled dose, and allowed to survive 1, 3, or 10 days. We show by histology and autoradiography that the chronic hemiparkinsonian condition is characterized by selective unilateral loss of nigrostriatal dopamine neurons and absence of MPP+ retention in the caudate-putamen. In the acute conditions, MPP+ is accumulated and selectively retained in high concentrations in the caudate-putamen bilaterally and throughout the nigrostriatal pathway only on the side receiving the toxic dose. In the substantia nigra pars compacta, MPP+ is accumulated in very low concentrations in the dopamine cell bodies and is not selectively retained there. At 10 days survival, the caudate-putamen on the side receiving the toxic dose loses its ability to retain MPP+. The apparent degeneration of the dopamine axon terminals in the caudate-putamen and the development of Parkinson-like behavioral signs seen at 10 days survival were observed to precede the loss of cell bodies in the substantia nigra, which appeared normal by the criteria of Nissl staining and neuromelanin content at all time points in the acute conditions. Other areas of dense MPP+ retention in all cases include noradrenergic and serotonergic cell groups and noradrenergic pathways. MPP+ in the locus coeruleus and other caudal catecholaminergic cell groups is apparently retrogradely transported there after uptake in terminal regions, and although it is retained in high concentrations, no cell loss occurs. These findings suggest that experimentally induced Parkinsonism results from molecular events initiated in the neostriatum and selectively elaborated in the nigrostriatal pathway, ultimately resulting in the death of substantia nigra pars compacta dopamine neurons. They do not support a significant role for neuromelanin binding in the toxicity of MPP+." @default.
• W2002186719 created "2016-06-24" @default.
• W2002186719 creator A5004833568 @default.
• W2002186719 creator A5029019087 @default.
• W2002186719 creator A5050088244 @default.
• W2002186719 creator A5057152956 @default.
• W2002186719 creator A5073802721 @default.
• W2002186719 creator A5086602178 @default.
• W2002186719 date "1991-01-01" @default.
• W2002186719 modified "2023-09-23" @default.
• W2002186719 title "Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: An in vivo autoradiographic study" @default.
• W2002186719 cites W1967192942 @default.
• W2002186719 cites W1969800514 @default.
• W2002186719 cites W1981823905 @default.
• W2002186719 cites W1986245765 @default.
• W2002186719 cites W1992961435 @default.
• W2002186719 cites W1997065612 @default.
• W2002186719 cites W1999975257 @default.
• W2002186719 cites W2000956059 @default.
• W2002186719 cites W2001351092 @default.
• W2002186719 cites W2030388326 @default.
• W2002186719 cites W2031639949 @default.
• W2002186719 cites W2032725923 @default.
• W2002186719 cites W2035667968 @default.
• W2002186719 cites W2041734419 @default.
• W2002186719 cites W2042978597 @default.
• W2002186719 cites W2043372243 @default.
• W2002186719 cites W2051094114 @default.
• W2002186719 cites W2051703627 @default.
• W2002186719 cites W2055715560 @default.
• W2002186719 cites W2067071952 @default.
• W2002186719 cites W2069123932 @default.
• W2002186719 cites W2069765052 @default.
• W2002186719 cites W2072190564 @default.
• W2002186719 cites W2086208850 @default.
• W2002186719 cites W2100796182 @default.
• W2002186719 cites W2107878786 @default.
• W2002186719 cites W4243911795 @default.
• W2002186719 cites W2090497955 @default.
• W2002186719 doi "https://doi.org/10.1016/0306-4522(91)90180-v" @default.
• W2002186719 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2052148" @default.
• W2002186719 hasPublicationYear "1991" @default.
• W2002186719 type Work @default.
• W2002186719 sameAs 2002186719 @default.
• W2002186719 citedByCount "164" @default.
• W2002186719 countsByYear W20021867192012 @default.
• W2002186719 countsByYear W20021867192013 @default.
• W2002186719 countsByYear W20021867192014 @default.
• W2002186719 countsByYear W20021867192015 @default.
• W2002186719 countsByYear W20021867192016 @default.
• W2002186719 countsByYear W20021867192017 @default.
• W2002186719 countsByYear W20021867192018 @default.
• W2002186719 countsByYear W20021867192019 @default.
• W2002186719 countsByYear W20021867192020 @default.
• W2002186719 countsByYear W20021867192021 @default.
• W2002186719 countsByYear W20021867192022 @default.
• W2002186719 countsByYear W20021867192023 @default.
• W2002186719 crossrefType "journal-article" @default.
• W2002186719 hasAuthorship W2002186719A5004833568 @default.
• W2002186719 hasAuthorship W2002186719A5029019087 @default.
• W2002186719 hasAuthorship W2002186719A5050088244 @default.
• W2002186719 hasAuthorship W2002186719A5057152956 @default.
• W2002186719 hasAuthorship W2002186719A5073802721 @default.
• W2002186719 hasAuthorship W2002186719A5086602178 @default.
• W2002186719 hasConcept C126322002 @default.
• W2002186719 hasConcept C134018914 @default.
• W2002186719 hasConcept C137183658 @default.
• W2002186719 hasConcept C170493617 @default.
• W2002186719 hasConcept C185592680 @default.
• W2002186719 hasConcept C2775864247 @default.
• W2002186719 hasConcept C2776355744 @default.
• W2002186719 hasConcept C2776773494 @default.
• W2002186719 hasConcept C2778674702 @default.
• W2002186719 hasConcept C2779714222 @default.
• W2002186719 hasConcept C2780938664 @default.
• W2002186719 hasConcept C2781423529 @default.
• W2002186719 hasConcept C42251903 @default.
• W2002186719 hasConcept C513476851 @default.
• W2002186719 hasConcept C71924100 @default.
• W2002186719 hasConcept C86803240 @default.
• W2002186719 hasConceptScore W2002186719C126322002 @default.
• W2002186719 hasConceptScore W2002186719C134018914 @default.
• W2002186719 hasConceptScore W2002186719C137183658 @default.
• W2002186719 hasConceptScore W2002186719C170493617 @default.
• W2002186719 hasConceptScore W2002186719C185592680 @default.
• W2002186719 hasConceptScore W2002186719C2775864247 @default.
• W2002186719 hasConceptScore W2002186719C2776355744 @default.
• W2002186719 hasConceptScore W2002186719C2776773494 @default.
• W2002186719 hasConceptScore W2002186719C2778674702 @default.
• W2002186719 hasConceptScore W2002186719C2779714222 @default.
• W2002186719 hasConceptScore W2002186719C2780938664 @default.
• W2002186719 hasConceptScore W2002186719C2781423529 @default.
• W2002186719 hasConceptScore W2002186719C42251903 @default.
• W2002186719 hasConceptScore W2002186719C513476851 @default.
• W2002186719 hasConceptScore W2002186719C71924100 @default.
• W2002186719 hasConceptScore W2002186719C86803240 @default.
• W2002186719 hasIssue "1" @default.
• W2002186719 hasLocation W20021867191 @default.

• next